The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

Combined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes.

TitleCombined strength and aerobic training increases transforming growth factor-β1 in patients with type 2 diabetes.
Publication TypeJournal Article
Year of Publication2011
AuthorsTouvra, A-M., Volaklis K. A., Spassis A. T., Zois C. E., Douda H. D., Kotsa K., & Tokmakidis S. P.
JournalHormones (Athens)
Volume10
Issue2
Pagination125-30
Date Published2011 Apr-Jun
ISSN1109-3099
KeywordsDiabetes Mellitus, Type 2, Exercise, Female, Hemoglobin A, Glycosylated, Humans, Male, Middle Aged, Muscle Strength, Physical Fitness, Resistance Training, Transforming Growth Factor beta1
Abstract

OBJECTIVE: The aim of the present study was to examine the effects of a combined strength and aerobic training program on pro- and anti-inflammatory cytokines and transforming growth factor-β1 in patients with type 2 diabetes.DESIGN: Ten patients with type 2 diabetes, aged 55.5 (5) years [median (IQR)] participated in a supervised systematic exercise training program which included aerobic exercise and strength training, undertaken four days per week for eight weeks.RESULTS: The training program increased transforming growth factor-β1 concentration (+50.4%) and reduced high sensitivity C reactive protein levels (-24.1%) without altering the levels of interleukin-6, interleukin-10, interferon-γ and tumor necrosis factor-α. Additional improvements were also achieved in anthropometric characteristics, glycated hemoglobin (HbA1c: -11.8%), homeostasis model assessment of insulin resistance index (HOMA-IR: -15%) and physical fitness parameters (stress test: +26.6%, upper muscle strength: +32.4% and lower muscle strength: +48.9%).CONCLUSION: A combined strength and aerobic exercise program has a potential anti-atherogenic and anti-inflammatory impact which most likely reduces the risk of cardiovascular disease and improves the health status in patients with type 2 diabetes.

Alternate JournalHormones (Athens)
PubMed ID21724537

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.